Search

Author/Creator Majewski, Michal

1. Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. Issue 10 (25th May 2022)

Authors:
Sharma, Shringi; Pepin, Xavier; Cheung, Jean; Zheng, Lianqing; Wei, Hua; Townsley, Danielle; Han, David; Majewski, Michal; Ware, Joseph A.; Mann, James; Munugalavadla, Veerendra; Sheridan, Louise; Patel, Priti; Gupta, Ashok; Tomkinson, Helen
Other Names:
Gacia‐Bournissen Facundo guestEditor.; Rieder Michael guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 10(2022)
Page Start:
4573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors. Issue 11 (27th August 2022)

Authors:
Sharma, Shringi; Pepin, Xavier; Burri, Harini; Zheng, Lianqing; Kuptsova‐Clarkson, Nataliya; de Jong, Anouk; Yu, Ting; MacArthur, Holly L.; Majewski, Michal; Byrd, John C.; Furman, Richard R.; Ware, Joseph A.; Mann, James; Ramies, David; Munugalavadla, Veerendra; Sheridan, Louise; Tomkinson, Helen
Journal:
Clinical pharmacology in drug development
Issue:
Volume 11:Issue 11(2022)
Page Start:
1294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗